Pnc Financial Services Group, Inc. Biomarin Pharmaceutical Inc Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 12,816 shares of BMRN stock, worth $720,771. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,816
Previous 12,166
5.34%
Holding current value
$720,771
Previous $799,000
13.27%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding BMRN
# of Institutions
668Shares Held
184MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.28 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.07 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$841 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$607 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.5B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...